Pompe Disease Late-Onset
30
4
10
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
27%
8 trials in Phase 3/4
36%
5 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (30)
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)
Pompe Pregnancy Sub-Registry
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)
Gene Transfer Study in Patients With Late Onset Pompe Disease
ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD
Developing a Management Approach for Patients With "Late-Onset" Pompe Disease
A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
MSOT in Pompe Disease
A Gene Transfer Study for Late-Onset Pompe Disease (RESOLUTE)
Treatment Frequency Reduction in Pompe Disease
Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease
Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease
Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease
Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders